Wells Fargo & Company Lensar, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Lensar, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 189 shares of LNSR stock, worth $2,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189

Previous 189 -0.0%

Holding current value

$2,421

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.0 - $4.88 $216 - $351	-72 Reduced 27.59%	189 $0
Q1 2024 May 10, 2024	SELL	$3.25 - $5.0 $1,098 - $1,690	-338 Reduced 56.43%	261 $0
Q4 2023 Feb 09, 2024	BUY	$2.01 - $3.51 $275 - $480	137 Added 29.65%	599 $2,000
Q3 2023 Nov 13, 2023	SELL	$3.02 - $4.45 $6 - $8	-2 Reduced 0.43%	462 $1,000
Q2 2023 Aug 15, 2023	SELL	$2.3 - $4.34 $683 - $1,288	-297 Reduced 39.03%	464 $1,000
Q1 2023 May 12, 2023	BUY	$2.19 - $3.27 $665 - $994	304 Added 66.52%	761 $1,000
Q4 2022 Feb 13, 2023	BUY	$2.7 - $5.9 $2 - $5	1 Added 0.22%	457 $1,000
Q3 2022 Nov 14, 2022	SELL	$4.94 - $7.0 $64 - $91	-13 Reduced 2.77%	456 $2,000
Q2 2022 Aug 12, 2022	BUY	$6.15 - $7.94 $43 - $55	7 Added 1.52%	469 $3,000
Q4 2021 Feb 14, 2022	SELL	$5.9 - $7.84 $41 - $54	-7 Reduced 1.49%	462 $2,000
Q3 2021 Nov 15, 2021	BUY	$7.5 - $8.88 $367 - $435	49 Added 11.67%	469 $4,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $8.66 $494,667 - $623,554	-72,004 Reduced 99.42%	420 $4,000
Q1 2021 May 13, 2021	BUY	$6.28 - $9.56 $340,966 - $519,050	54,294 Added 299.47%	72,424 $525,000
Q4 2020 Feb 09, 2021	BUY	$6.7 - $12.2 $121,471 - $221,186	18,130 New	18,130 $131,000

Others Institutions Holding LNSR

# of Institutions

Shares Held

4.72M

Call Options Held

12.2K

Put Options Held

30.6K

View Full List

About LENSAR, Inc.

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $141M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

More about LNSR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Lensar, Inc. Transaction History